Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | COG-ANHL12P1 A Randomized Phase II study of Brentuximab Vedotin (NSC 749710) and Crizotinib (NSC 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND 117117 |
|---|---|
| Full Title | COG-ANHL12P1 A Randomized Phase II study of Brentuximab Vedotin (NSC 749710) and Crizotinib (NSC 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND 117117 |
| Disease/Condition | Pediatric Hematology/Oncology |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Jonathan Gill |
| Contact Name | Joyce Brown |
| Contact Email | jivanova@montefiore.org |
| Protocol Number | IRB# 2015-4858 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | No |
| Adult, Pediatric, Both | Adult |
